Impact of stress on the development of cardiovascular diseases

DOI: https://doi.org/10.29296/25877305-2019-07-15
Номер журнала: 
7
Год издания: 
2019

T. Potupchik(1), Candidate of Medical Sciences; L. Evert(2), MD; O. Averyanova(3); Yu. Akhmeldinova(1) 1-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University 2-Research Institute for Medical Problems of the North, Federal Research Center «Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences» 3-Krasnoyarsk Interdistrict Maternity Hospital Four

The paper describes the impact of stress on the cardiovascular system and the development of cardiovascular diseases and considers the possibilities of their correction using the combined drug Stressovit. It also depicts numerous positive effects of Stressovit, the components of which contribute to relieving emotional stress, nervousness, anxiety, and irritability, increasing stress resistance, improving mood, enhancing mental and physical performance, and eliminating the autonomic manifestations of stress. Stressovit has a good safety profile and can be recommended for cardiovascular diseases.
Keywords: 
neurology, cardiology, Stressovit, cardiovascular diseases, stress, pyridoxine, magnesium, motherwort (Leonurus cardiaca), hops (Humulus) infructescences, linden (Tilia) flowers

Список литературы: 
  1. Bajgarin E.K., Bakumenko O.E., Bajkov V.G. i dr. Razrabotka napitka na osnove rastitel'nogo syr'ja dlja profilaktiki gipertonii // Voprosy pitanija. – 2014; 8 (3): 167–8 [Baigarin E.K., Bakumenko O.E., Baikov V.G. et al. Development of drink on the basis of vegetable raw materials for prevention of hypertension // Voprosy pitaniya. – 2014; 8 (3): 167–8 (in Russ.)].
  2. Bojtsov S.A., Balanova Ju.A., Shal'nova S.A. i dr. Arterial'naja gipertonija sredi lits 25–64 let: rasprostranennost', osvedomlennost', lechenie i kontrol'. Po materialam issledovanija ESSE // Kardiovask. ter. i profilakt. – 2014; 4: 4–14 [Boytsov S.A., Balanova U.A., Shalnova, S.A. et al. Hypertension among persons 25–64 years of age: prevalence, awareness, treatment and control. According to studies ESSAY // Kardiovask. ter. i profilakt. – 2014; 4: 4–14 (in Russ.)]. DOI: 10.15829/1728-8800-2014-4-4-14.
  3. Borisov I.A., Gurak S.I. Faktory riska razvitija serdechno-sosudistyh zabolevanij i ih vozmozhnosti korrektsii v uslovijah polikliniki // Vrach. – 2005; 11: 38–40 [Borisov I.A., Gura S.I. risk Factors for cardiovascular diseases and their possibility of correction in a polyclinic // Vrach. – 2005; 11: 38–40 (in Russ.)].
  4. Voznesenskaja T.G. Emotsional'nyj stress i profilaktika ego posledstvij // Russ. med. zhurn. – 2006; 14 (9): 694–8 [Voznesenskaya T.G. Emotional stress and prevention of its consequences // Russ. med. zhurn. – 2006; 14 (9): 694–8 (in Russ.)].
  5. Vorob'eva O.V. Stressindutsirovannye psihovegetativnye reaktsii // Russ. med. zhurn. – 2005; 12: 798–801 [Vorobyova O.V. Stress induced psychovegetative reactions // Russ. med. zhurn. – 2005; 12: 798–801 (in Russ.)].
  6. Gimaeva Z.F., Karimova L.K., Bakirov A.B. i dr. Riski razvitija serdechno-sosudistyh zabolevanij i professional'nyj stress // Analiz riska zdorov'ju. – 2017; 1: 106–15 [Gimaeva Z.F., Karimova L.K., Bakirov A.B. et al. Risks of developing cardiovascular diseases and occupational stress // Analiz riska zdorov’yu. – 2017; 1: 106–15 (in Russ.)]. DOI: 10.21668/health.risk/2017.1.12.
  7. Danilov S.A., Shtrygol' S.Ju., Dmitrievskij D.I. i dr. Sravnitel'noe izuchenie nejroprotektornoj aktivnosti preparatov pustyrnika // Klinichna farmakologija. – 2011; 15 (4): 64–8 [Danilov, S.A., Strigol S.J., Demetrius D.I. et al. A comparative study of the neuroprotective activity of the extracts of motherwort // Kliniczna pharmacology. – 2011; 15 (4): 64–8 (in Russ.)].
  8. Karomatov I.D., Atamuradova Sh.T. Pischevoe i lechebnoe znachenie rastenija hmel' obyknovennyj // Biologija i integrativnaja meditsina. – 2018; 1: 187–212 [Karamatov I.D., Atamuradova S.T. Nutritional and therapeutic value of the plant hops ordinary // Biology and integrative medicine. – 2018; 1: 187–212 (in Russ.)].
  9. Karomatov I.D., Halilova R.S. Pustyrnik serdechnyj izvestnoe lekarstvennoe rastenie // Biologija i integrativnaja meditsina. – 2017; 11: 236–43 [Karomatov I.D., Khalilova R.S. Pustyrnik cordial known medicinal plant // Biology and integrative medicine. – 2017; 11: 236–43 (in Russ.)].
  10. Kushnerova N.F., Merzljakov V.Ju., Fomenko S.E. i dr. Profilaktika stressovyh narushenij u meditsinskih rabotnikov // Meditsina truda i promyshlennaja ekologija. – 2012; 6: 44–8 [Kushnerova N.F., Merzlyakov V.Yu., Fomenko S.E. et al. Prevention of stress disorders in medical professionals // occupational // Medicine and industrial ecology. – 2012; 6: 44–8 (in Russ.)].
  11. Medvedeva T.M., Bolotova V.Ts., Kauhova I.E. i dr. Izuchenie nejrotropnoj aktivnosti granul na osnove suhogo ekstrakta lipy serdtsevidnoj list'ev // Sibirskij med. zhurn. (Tomsk). – 2011; 26 (2–2): 78–81 [Medvedeva T.M., Bolotov V.C., Kauhava E.I. et al. the Study of neurotropic activity of granules on the basis of dry extract of Linden heart-shaped leaves // Siberian medical journal (Tomsk). – 2011; 26 (2–2): 78–81 (in Russ.)].
  12. Nikitina Ju., Kopylov F. Psihosomaticheskie aspekty serdechno-sosudistyh zabolevanij // Vrach. – 2009; 12: 21–5 [Nikitina Yu., Kopylov F. Psychosomatic aspects of cardiovascular diseases // Vrach. – 2009; 12: 21–5 (in Russ.)].
  13. Razuvaeva Ja.G., Toropova A.A., Kuharenko N.S. i dr. Stress-protektivnoe i antioksidantnoe vlijanie suhogo ekstrakta iz humulus lupulus pri dlitel'nom emotsional'nom stresse // Bjulleten' Vostochno-Sibirskogo Nauchnogo tsentra Sibirskogo otdelenija Rossijskoj akademii meditsinskih nauk. – 2014; 6 (100): 73–6 [Razuvaeva Ya.G., Toropova A.A., Kukharenko N.S. et al. Stress-protective and antioxidant effect of dry extract from humulus lupulus under prolonged emotional stress // Bulletin of the East Siberian Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences. – 2014; 6 (100): 73–6 (in Russ.)].
  14. Sel'e G. Stress bez distressa. Per. s angl.; obsch. red. E.M. Krepsa / M.: Progress, 1979; 124 s. [Sel’e G. Stress bez distressa. Per. s angl.; obshch. red. E.M. Krepsa / M.: Progress, 1979; 124 s (in Russ.)].
  15. Shal'nova S.A., Balanova Ju.A., Konstantinov V.V. i dr. Arterial'naja gipertonija: rasprostranennost', osvedomlennost', priem antigipertenzivnyh preparatov i effektivnost' lechenija sredi naselenija Rossijskoj Federatsii // Ros. kardiol. zhurn. – 2006; 60 (4): 45–50 [Shalnova S.A. Balanova Yu.A., Konstantinov V.V. et al. Arterial hypertension: prevalence, awareness, administration of antihypertensive drugs and effectiveness of treatment among the population of the Russian Federation // Ros. kardiol. zhurn. – 2006; 60 (4): 45–50 (in Russ.)].
  16. Aguirre-Hernandez E., Martinez A., Gonzalez-Trujano M. et al. Pharmacological evaluation of the anxiolytic and sedative effects of Tilia americana L. var. mexicana in mice // J. Ethnopharmacol. – 2007; 109 (1): 140–5.
  17. Albini A., Dell’Eva R., Vené R. et al. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets // FASEB J. – 2006; 20 (3): 527–9.
  18. Bernatoniene J., Kopustinskiene D., Jakstas V. et al. The effect of Leonurus cardiaca herb extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart // Planta Med. – 2014; 80 (7): 525–32. DOI: 10.1055/s-0034-1368426.
  19. Boyle N., Lawton C., Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress // A Systematic Review Nutrients. – 2017; 9: 429. DOI:10.3390.
  20. Busch C., Noor S., Leischner C. et al. Anti-proliferative activity of hop-derived prenylflavonoids against human cancer cell lines // Wien. Med. Wochenschr. – 2015; 165 (11–12): 258–61. DOI: 10.1007/s10354-015-0355-8.
  21. Ceremuga T., Johnson L., Adams-Henderson J. et al. Investigation of the anxiolytic effects of xanthohumol, a component of humulus lupulus (Hops), in the male Sprague-Dawley rat // AANA J. – 2013; 81 (3): 193–8.
  22. European Medicines Agency. Assessment report on Tilia cordata Miller, Tilia platyphyllos Scop., Tilia vulgaris Heyne or their mixtures, flos / EMA/HMPC/337067/2011.
  23. Fatemeh Abdi, Hamid Mobedi, Nasibeh Roozbeh. Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action // J. Menopausal Med. – 2016; 22: 62–4. DOI: 10.6118/jmm.2016.22.2.62.
  24. Grober U., Schmidt J., Kisters K. Review Magnesium in Prevention and Therapy // Nutrients. – 2015; 7: 8199–226. DOI: 10.3390/nu7095388.
  25. Hellmann H., Mooney S. Vitamin B6: A Molecule for Human Health? // Molecules. – 2010; 15: 442–59. DOI: 10.3390/molecules15010442.
  26. Hoven H., Wahrendorf M., Siegrist J. Occupational position, work stress and depressive symptoms: a pathway analysis of longitudinal SHARE data // J. Epidemiol. Community Health. – 2015; 69 (5): 447–52. DOI: 10.1136/jech-2014-205206.
  27. Karasek R., Theorell T. Healthy Work: Stress, productivity and the reconstruction of working life Basic / New York: Basic Books Inc., 1990; 381 r.
  28. Ktosek M., Mertas A., Krol W. et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Prostate Cancer Cells after Treatment with Xanthohumol-A Natural Compound Present in Humulus lupulus L // Int. J. Mol. Sci. – 2016; 17 (6): 837. DOI: 10.3390/ijms17060837.
  29. Kyrou I., Christou A., Panagiotakos D. et al. Effects of hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized, placebo-controlled, double-blind, crossover pilot study // Hormones (Athens). – 2017; 16 (2): 171–80. DOI: 10.14310/horm.2002.1738.
  30. Lunau T., Wahrendorf M., Dragano N. et aal. Work stress and depressive symptoms in older employees: impact of national labour and social policies // BMC Public Health. – 2013; 13: 1086. DOI: 0.1186/1471-2458-13-1086.
  31. Milkowska-Leyck K., Filipek B., Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca // J. Ethnopharmacol. – 2002; 80 (1): 85–90.
  32. Orhan I., Gokbulut A., Senol F. Adonis sp., Convallaria sp., Strophanthus sp., Thevetia sp., and Leonurus sp. – Cardiotonic Plants with Known Traditional Use and a Few Preclinical and Clinical Studies // Curr. Pharm. Des. – 2017; 23 (7): 1051–9. DOI: 10.2174/1381612822666161010104548.
  33. Ritter M., Melichar K., Strahler S. et al. Cardiac and electrophysiological effects of primary and refined ex-tracts from Leonurus cardiaca L. (Ph.Eur.) // Planta Med. – 2010; 76 (6): 572–82.
  34. Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease? // Am. J. Cardiovasc. Drugs. – 2003; 3 (4): 231–9.
  35. Shechter M., Sharir M., Labrador M. et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. // Circulation. – 2000; 1: 2353–8.
  36. Shikov A., Pozharitskaya O., Makarov V. et al. Effect of Leonurus cardiac oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders // Phytother. Res. – 2011; 25 (4): 540–3.
  37. Slawinska-Brych A., Król S., Dmoszynska-Graniczka M. et al. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro // Chem. Biol. Interact. – 2015; 5: 110–8. DOI: 10.1016/j.cbi.2015.08.008.
  38. Song X., Wang T., Zhang Z. et al. Leonurine exerts anti-inflammatory effect by regulating inflammatory signaling pathways and cytokines in LPS-induced mouse mastitis // Inflammation. – 2015; 38 (1): 79–88.
  39. Swaminathan R. Magnesium Metabolism and its Disorders // Clin. Biochem. Rev. – 2003; 24 (2): 47–66.
  40. Ueshima K. Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences // Magnes Res. – 2005; 8 (4): 275–84.
  41. Wojtyniak K., Szymanski M., Matlawska I. Leonurus cardiaca L. (Motherwort): A Review of its Phytochemistry and Pharmacology // Phytother. Res. – 2013; 27 (8): 1115–20. DOI: 10.1002/ptr.4850.
  42. Yen T., Hsu C., Lu W. et al. Neuroprotective effects of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), in ischemic stroke of rats // J. Agric. Food Chem. – 2012; 60 (8): 1937–44.
  43. Zanoli P., Zavatti M., Rivasi M. et al. Evidence that the beta-acids fraction of hops reduces central GABAergic neurotransmission // J. Ethnopharmacol. – 2007; 109: 87–92.
  44. Hamer M., Stamatakis E., Steptoe A. Psychiatric hospital admissions, behavioral risk factors, and allcause mortality: the Scottish health survey // Arch. Intern. Med. – 2008; 168 (22): 2474–9.
  45. Oganov R.G., Pogosova G.V., Koltunov I.E. i dr. Depressivnaja simptomatika uhudshaet prognoz serdechno-sosudistyh zabolevanij i snizhaet prodolzhitel'nost' zhizni bol'nyh arterial'noj gipertoniej i ishemicheskoj bolezn'ju serdtsa // Kardiologija. – 2011; 51 (2): 59–66 [Oganov R.G., Pogosova G.V., Koltunov I.E. et al. Depressive Symptoms Worsen Cardiovascular Prognosis and Shortens Length of Life in Patients With Arterial Hypertension and Ischemic Heart Disease // Kardiologiya. – 2011; 51 (2): 59–66 (in Russ.)].
  46. Chazov E.I., Oganov R.G., Pogosova G.V. i dr. Depressivnaja simptomatika uhudshaet prognoz u bol'nyh arterial'noj gipertoniej i ishemicheskoj bolezn'ju serdtsa: pervye rezul'taty prospektivnogo etapa rossijskogo mnogotsentrovogo issledovanija «KOORDINATA» // Kardiologija. – 2007; 41 (10): 24–30 [Chazov E.I., Oganov R.G., Pogosova G.V. et al.Depressive Symptoms Worsen Prognosis in Patients With Arterial Hypertension and Ischemic Heart Disease: First Results of Prospective Phase of Russian Multicenter Study COORDINATA // Kardiologiya. – 2007; 41 (10): 24–30 (in Russ.)].